Position in ZYME
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,202,440
+$50,600 QoQ
Shares Held
46,000
0.0% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#4
of 22 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026North Growth Management Ltd. holds $1,202,440 across 1 Biotechnology name. ZYME ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZYME |
Zymeworks Inc.
This page
|
46,000 | $1,202,440 |
All Filings in ZYME
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,202,440 | 46,000 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,151,840 | 46,000 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,184,850 | 45,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,400,560 | 82,000 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,217,350 | 97,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,155,270 | 97,000 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,420,080 | 97,000 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,217,350 | 97,000 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $825,470 | 97,000 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,020,440 | 97,000 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,007,830 | 97,000 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $614,980 | 97,000 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $1,036,800 | 120,000 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $1,084,800 | 120,000 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $589,500 | 75,000 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||